22Indexed trials
mesh condition
Cardiovascular Diseases
Intelligence
Cardiovascular Diseases intelligence: 22 indexed trials, 8 recruiting studies, 21 sponsors across 35 countries.
8Recruiting
21Sponsors
35Countries
Leading sponsors
Columbia University21 recruiting
Baylor Research Institute10 recruiting
Bjorn H. Ebdrup11 recruiting
China Medical University Hospital10 recruiting
Health Service Executive, Ireland11 recruiting
Insel Gruppe AG, University Hospital Bern11 recruiting
King's College London11 recruiting
National Heart, Lung, and Blood Institute (NHLBI)10 recruiting
National Human Genome Research Institute (NHGRI)10 recruiting
Ottawa Heart Institute Research Corporation11 recruiting
Peerbridge Health, Inc10 recruiting
Pfizer10 recruiting
Geographic activity
United States10trials
United Kingdom3trials
Netherlands3trials
Spain2trials
Switzerland2trials
Ireland2trials
Taiwan2trials
Denmark2trials
Canada2trials
Colombia1trials
Germany1trials
Chile1trials
Leading interventions
A combination of various test and biomarkers will be completed to understand the effect of hypertensive disorders of pregnancy in brain health in midlife.1trials
Approach A (PeeSpot urine collection device).1trials
Approach B (ACR | EU Test kit).1trials
Blinded to Genetic Testing Results1trials
COR Wearable ECG Monitoring1trials
Conventional pacemaker DDD1trials
Cor360 Clinician-Facing Decision-Aid Reporting1trials
Exercise1trials
Leadless pacemaker Micra AV1trials
Propranolol1trials
Referral as Usual (RAU)1trials
SBIRT1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.